| |
|
|
|
Aldeyra Therapeutics- Inc.  
|
|
8.7 0.1 (0.01%) |
06-20 15:07 |
|
Open: |
8.9 |
Pre close: |
8.6 |
Target:
|
10.86 
|
|
High: |
8.9 |
Low: |
8.7 |
Resistance:
|
9.30
10.86
|
|
Volume: |
103,263 |
Market Cap: |
175M |
Support:
|
8.53
8.05
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.71
|
MACD |
MACD(12,26):
|
0.14 |
|
MA(20): |
8.50 |
Signal(12,26,9): |
0.13 |
|
MA(100): |
7.91 |
Stochastic Oscillator |
%K(14,3):
|
70.37  |
|
MA(250): |
6.75 |
%D(3): |
72.22 |
|
Average Volume(K) |
3-Month: |
9170
|
52-Week |
High:
|
11.90 |
|
10-Days: |
9977 |
Low: |
3.90 |
|
RSI |
RSI(14):
|
58.71 |
Change(%): |
107.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.470 |
Return on Equity (ttm) |
-75.0 |
Shares Out. (M) |
20.11 |
|
EPS Est. Current Year |
-1.470 |
Return on Assets (ttm) |
-66.4 |
Shares Float (M) |
19.69 |
|
EPS Est. Next Year |
-1.740 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.370 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
43.80 |
|
Forward EPS |
-2.372 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
87 |
|
Book Value (p.s.) |
4.830 |
EBITDA (p.s.) |
-0.508 |
P/E |
-5.99 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.82 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-19.22 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-11.16 |
P/CF |
-9.21 |
|
|
|
|
|
|
